Invention Grant
- Patent Title: Mebeverine as soluble epoxide hydrolase inhibitor
-
Application No.: US17144471Application Date: 2021-01-08
-
Publication No.: US11766419B2Publication Date: 2023-09-26
- Inventor: Sarvesh Paliwal , Swapnil Sharma , Neetika Tripathi , Kanika Verma , Swati Paliwal
- Applicant: Banasthali Vidyapith
- Applicant Address: IN Banasthali
- Assignee: Banasthali Vidyapith
- Current Assignee: Banasthali Vidyapith
- Current Assignee Address: IN Banasthali
- Agency: Lucas & Mercanti, LLP
- Main IPC: A61K31/245
- IPC: A61K31/245 ; A61P3/06 ; A61P9/12 ; A61K9/20
Abstract:
The present invention relates to a method of using Mebeverine as an sEH inhibitor. The present invention also provides a method of treating metabolic and cardiovascular disorders using Mebeverine.
Public/Granted literature
- US20220218648A1 Mebeverine as soluble epoxy hydrolase inhibitor Public/Granted day:2022-07-14
Information query
IPC分类:
